Clinical Trial Site

Carshalton SM5 1AA

0 studies enrolling now · 3 studies all time

What they study most

ANCA-Associated Vasculitis, High Cardiovascular Risk, Hypertension

Studies at this site

• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2) — Completed
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed